MedPath

Deep Brain Stimulation of Nucleus Accumbens for Methamphetamine Addiction

Not Applicable
Conditions
Treatment Methamphetamine Addiction
Interventions
Procedure: Bilateral surgical implantation of DBS system to NAc
Registration Number
NCT03347474
Lead Sponsor
Ruijin Hospital
Brief Summary

The main objective of this study is to assess the efficacy of bilateral deep brain stimulation (DBS) of the Nucleus Accumbens(NAc) as a novel treatment in severe methamphetamine addiction. Our hypothesis is that bilateral DBS of the NAc will significantly reduce the craving for methamphetamine.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
10
Inclusion Criteria
  • DSM-IV-TR diagnosis of Drug addiction disorder;
  • Age 18-65 years old;
  • Proficiency in Mandarin language;
  • Failure to detox more than three times;
  • Capacity to provide informed consent (understanding of the study purpose and methods);
Exclusion Criteria
  • Multidrug abuse and formation of addiction;
  • Serious and unstable organic diseases (e.g. unstable coronal heart disease);
  • Any history of seizure disorder or hemorrhagic stroke;
  • Past stereotactic neurosurgical intervention;
  • Neurological disease (Abnormal PET-CT, MRI, EEG)
  • Contraindications of MRI-examination, e.g. implanted cardiac pacemaker/ heart defibrillator;
  • Contraindications of stereotactic intervention, e.g. increased bleeding disposition, cerebrovascular diseases (e.g. arteriovenous malfunction, aneurysms, systemic vascular diseases);
  • HIV positive;
  • Pregnancy and/or lactation;

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Bilateral surgical implantation of DBS system to NAcBilateral surgical implantation of DBS system to NAc-
Primary Outcome Measures
NameTimeMethod
change in 10-point visual analog scale of carvingBaseline (preoperative),3 months,6 months, 12 months

The score of scale is from 0 to 10. 0 represents no carving for drug, 10 means the greatest degree of carving for drug.

change in Obsessive Compulsive Drug Use ScaleBaseline (preoperative),3 months,6 months, 12 months
Secondary Outcome Measures
NameTimeMethod
Change in the Hamilton Anxiety ScaleBaseline(preoperative),3 months, 6 months, 12months
Change in the Hamilton Depression ScaleBaseline(preoperative),3 months, 6 months, 12 months
Change in the Quality of Life Assessment (SF-36)Baseline(preoperative),3 months, 6 months, 12 months
Chang in Pittsburgh Sleep Quality IndexBaseline(preoperative),3 months,6 months, 12 months
Neuropsychological measures(Scores of cognitive battery)Baseline(preoperative),6 months,12 months
Side EffectBaseline(preoperative),3 months, 6 months, 12months
Change in World Health Organization Quality of Life-BREF(WHO-BREF)Baseline(preoperative),3 months,6 months, 12 months
Change in Fagerstrom Test of Nicotine Dependence(FTND)Baseline(preoperative),3 months,6 months, 12 months

Trial Locations

Locations (1)

Shanghai Ruijin Hospital Functional Neurosurgery

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath